A peer-reviewed, pre-proof report to be published in the American Journal of Obstetrics and Gynecology found that mRNA from COVID-19 vaccines can “spread systematically” to the placenta and umbilical cord.
The study sought to analyze the “potential biodistribution of the vaccine’s mRNA to the placenta and or the fetus after maternal vaccination,” given that pregnant women were excluded from the initial COVID-19 mRNA vaccine trials.
To “assess the presence of COVID-19 vaccine mRNA in the placenta and cord blood,” the researchers vaccinated two pregnant women shortly before delivering the infants, one through vaginal delivery and the other by a cesarean section.
“Patient 1,” the woman planning to have a cesarean section, received four COVID-19 inoculations. There was a “notably high signal” of mRNA in the decidua tissue, an endometrium layer that protects the baby during pregnancy, the study found.
mRNA was discovered in the placenta of “patient 2,” the woman having a vaginal delivery, but not in “patient 1.”
The findings “suggest that the vaccine mRNA is not localized to the injection site and can spread systemically to the placenta and umbilical cord blood,” the researchers wrote.
The report noted that the mRNA’s integrity was less fragmented in the placenta than in the cord blood. “Notably, the vaccine mRNA was largely fragmented in the cord blood and, to a lesser extent, in the placenta. To our knowledge, these two cases demonstrate, for the first time, the ability of the COVID-19 103 vaccine mRNA to penetrate the fetal-placental barrier and reach the intrauterine environment.”
American Faith reported that miscarriage rates of doubled since the introduction of COVID-19 vaccines.
Representative Marjorie Taylor Greene (R-GA) asked Dr. Kimberly Biss, an OB-GYN who has been involved with 8,000 pregnancies, how many pregnant women experienced miscarriages after receiving the COVID-19 vaccines.
“How many of your patients or pregnant women that you know of experience miscarriages after taking the COVID-19 vaccines — or injections” Greene asked.
“I’ve never seen this before,” Biss responded, noting that patients inoculated in 2021 and 2022 are still having a “lingering effect.”
In 2020, Biss said that the miscarriage was about 4%. The number nearly doubled in 2021 to be between 7%-8%, and doubled again in 2022, rising to 15%.